Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
Rom S. Leidner, Kevin C. Conlon, Douglas G. McNeel, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007725-e007725
Open Access | Times Cited: 11

Showing 11 citing articles:

Research progress of interleukin-15 in cancer immunotherapy
Menghan Cai, Xuan Huang, Xiting Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 37
IL-15 in T-Cell Responses and Immunopathogenesis
Hoyoung Lee, Su‐Hyung Park, Eui‐Cheol Shin
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Synergistic Enhancement of Radio-immunotherapy Efficacy by IL-15 via Macrophage Activation and Memory T Cell Response
Peng Jin, Menglin Bai, Ji Li, et al.
Cancer Letters (2025), pp. 217511-217511
Open Access
The key role of immunomodulatory cytokines for the development of novel NK cell-based cancer therapies
A.A. Câmara, Diego Barriales, Ainara Azueta Etxebarría, et al.
International review of cell and molecular biology (2025)
Closed Access
IL-15: from discovery to FDA approval
Zihai Li, John Wrangle, Kai He, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Harnessing cytokine immunocomplexes and cytokine fusion proteins for cancer Therapy: Mechanisms and clinical potential
Wei Yang Kong, Amelia T. Soderholm, Andrew J. Brooks, et al.
Cancer Treatment Reviews (2025) Vol. 136, pp. 102937-102937
Open Access
Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer Xenografts
Stuart A. Clayton, Alan D. Mizener, Marcella Whetsell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Immunotherapy for gastric cancer: Advances and challenges
Pei Zhang, Chenyan Zhang, M Kellis, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer Xenografts
Stuart A. Clayton, Alan D. Mizener, Marcella Whetsell, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3640-3640
Open Access
Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity
John A. Hangasky, Rodrigo Fernández, Dimitris Stellas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top